CR20170222A - Anticuerpos heterodiméricos que se unen a cd3 y antígenos tumorales - Google Patents

Anticuerpos heterodiméricos que se unen a cd3 y antígenos tumorales

Info

Publication number
CR20170222A
CR20170222A CR20170222A CR20170222A CR20170222A CR 20170222 A CR20170222 A CR 20170222A CR 20170222 A CR20170222 A CR 20170222A CR 20170222 A CR20170222 A CR 20170222A CR 20170222 A CR20170222 A CR 20170222A
Authority
CR
Costa Rica
Prior art keywords
join
tumor antigens
heterodimeric antibodies
antibodies
heterodimeric
Prior art date
Application number
CR20170222A
Other languages
English (en)
Inventor
Sung-Hyung Lee
Matthew J Bernett
John Desjarlais
Gregory Moore
Rumana Rashid
Umesh Muchhal
Seung Y Chu
Original Assignee
Xencor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xencor Inc filed Critical Xencor Inc
Priority claimed from PCT/US2015/062772 external-priority patent/WO2016086189A2/en
Publication of CR20170222A publication Critical patent/CR20170222A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere a nuevos anticuerpos heterodiméricos
CR20170222A 2014-11-26 2015-11-25 Anticuerpos heterodiméricos que se unen a cd3 y antígenos tumorales CR20170222A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462084908P 2014-11-26 2014-11-26
US201462085027P 2014-11-26 2014-11-26
US201462085117P 2014-11-26 2014-11-26
PCT/US2015/062772 WO2016086189A2 (en) 2014-11-26 2015-11-25 Heterodimeric antibodies that bind cd3 and tumor antigens

Publications (1)

Publication Number Publication Date
CR20170222A true CR20170222A (es) 2017-09-29

Family

ID=60189875

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20170222A CR20170222A (es) 2014-11-26 2015-11-25 Anticuerpos heterodiméricos que se unen a cd3 y antígenos tumorales

Country Status (1)

Country Link
CR (1) CR20170222A (es)

Similar Documents

Publication Publication Date Title
GT201700112A (es) Anticuerpos heterodiméricos que se unen a cd3 y a antígenos tumorales
ECSP17081420A (es) Anticuerpos heterodiméricos que se unen a cd3 y a antígenos tumorales
CL2017001361A1 (es) Anticuerpos heterodiméricos que se unen a cd3 y cd38
CY1123236T1 (el) Αντισωματα διπλης εξειδικευσης που δεσμευονται με cd38 και cd3
ECSP17021175A (es) Terapias de combinación con anticuerpos anti-cd38
CR20170222A (es) Anticuerpos heterodiméricos que se unen a cd3 y antígenos tumorales
TH1501004169A (th) ส่วนสร้างแอนติบอดีสำหรับ cdh19 และ cd3
TH1601003592A (th) แอนติบอดีต่อต้าน cd3 และวิธีการใช้